Cellular Neonatal Fc Receptor Recycling Efficiencies can Differentiate Target-Independent Clearance Mechanisms of Monoclonal Antibodies
Authors:
Open Access
- 19 June 2024
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 113 (9) , 2879-2894
Abstract
No abstract availableKeywords
Funding Information
- Amgen Inc
This publication has 96 references indexed in Scilit:
- Methods for Functional Characterization of FcRn Interactions with Therapeutic Antibodies and Fc-Fusion Proteins2021
- Target‐Driven Pharmacokinetics of Biotherapeutics2015
- Target‐Driven Pharmacokinetics of Biotherapeutics2015
- Fusion Proteins for Half-Life Extension of Biologics as a Strategy to Make BiobettersBioDrugs, 2015
- Dynamics of target-mediated drug disposition: characteristic profiles and parameter identificationJournal of Pharmacokinetics and Pharmacodynamics, 2012
- Population PK and IgE Pharmacodynamic Analysis of a Fully Human Monoclonal Antibody Against IL4 ReceptorPharmaceutical Research, 2011
- Human FcRn Transgenic Mice for Pharmacokinetic Evaluation of Therapeutic Antibodies2006
- Pharmacokinetic aspects of biotechnology productsJournal of Pharmaceutical Sciences, 2004
- Mapping the site on human IgG for binding of the MHC class I-related receptor, FcRnEuropean Journal of Immunology, 1999
- Abnormally short serum half‐lives of IgG in β2‐microglobulin‐deficient miceEuropean Journal of Immunology, 1996